Inspire Medical enters $75M accelerated share repurchase with Goldman Sachs

Inspire Medical Systems, Inc.

ASR agreement for $75M repurchase under existing $150M buyback program authorized by Board.
Payment of $75M on Nov 12; initial delivery of shares worth 80% of repurchase price based on Nov 8 close.
Final settlement in Q1 2025; Inspire may receive additional shares or pay cash to GS&Co. under terms.
ASR contains standard provisions for adjustments, early termination, and representations by both parties.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.